Top

Published in:

Open Access 01-01-2014 | Letter to the Editor

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

Authors: Cihan Comba, Funda Gungor Ugurlucan, Ercan Bastu, Ahmet Cem Iyibozkurt, Samet Topuz

Published in: Archives of Gynecology and Obstetrics | Issue 1/2014

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a life- threatening complication of controlled ovarian stimulation. One of the main symptoms of OHSS is ascites. Treatment is symptomatic with resolution of the symptoms over days to weeks. We report a case of severe OHSS with persistent ascites 18 months after the diagnosis. Persistent ascites secondary to OHSS was diagnosed and single dose leuprolide acetate depot 11.25 mg was administered. At follow-up, no ascites was observed.

Ugurlucan FG, Iyibozkurt AC, Baysal B (2012) Ovarian hyperstimulation syndrome in a patient with frozen-thawed embryo transfer and dichorionic diamniotic pregnancy. Arch Gynecol Obstet 285:1759–1761CrossRef

Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A (2010) Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 28(6):448–457PubMedCrossRef

Kumar P, Sait SF, Sharma A, Kumar M (2011) Ovarian hyperstimulation syndrome. J Hum Reprod Sci 4(2):70–75PubMedCentralPubMedCrossRef

Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 11:1381–1386PubMedCrossRef

Kol S (2004) Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 81:1–5PubMedCrossRef

Shalev E, Geslevich Y, Ben-Ami M (1994) Induction of preovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Hum Reprod 9:417–419PubMed

Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 56:213–220PubMed

Itskovitz-Eldor J, Kol S, Mannaerts B (2000) Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian hyperstimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report. Hum Reprod 15:1965–1968PubMedCrossRef

Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89:84–91PubMedCrossRef

10.

DiLuigi AJ, Engmann L, Schmidt DW, Maier DB, Nulsen JC, Benadiva CA (2010) Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril 94(3):1111–1114PubMedCrossRef

11.

Kitajima Y, Endo T, Manase K, Nishikawa A, Shibuya M, Kudo R (2004) Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats. Fertil Steril 81(1):842–849PubMedCrossRef

12.

Dugernier T, Laterre PF, Reynaert MS (2000) Ascites fluid in severe acute pancreatitis: from pathophysiology to therapy. Acta Gastroenterol Belg 63:264–268PubMed

Title: Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome
Authors: Cihan Comba
Funda Gungor Ugurlucan
Ercan Bastu
Ahmet Cem Iyibozkurt
Samet Topuz
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 1/2014
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-2940-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

The timing of amniotomy, oxytocin and neuraxial analgesia and its association with labour duration and mode of birth

The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care

Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis

Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta

Work–life balance of German gynecologists: a web-based survey on satisfaction with work and private life

Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program